Advancing Science.
Designing Hope.
Innovative molecules and compelling combinations
Preclinical
Phase 1
Phase 2
Phase 3
Status
EOS-984: Small molecule targeting ENT1
Data Anticipated 2H25
EOS-215: mAb targeting TREM2
Enrolling